Drug interactions and pharmacokinetics of psychotropics - Part 1: Basics;Interaktionen und pharmakokinetik von psychopharmaka - Teil 1: Grundlagen

Neuropsychiatrie

Volumn 17, Issue 2, 2003, Pages 44-50

  Aichhorn, W ^a   Stuppack C ^b  

^a UNIVERSITY HOSPITAL INNSBRUCK   (Austria)

^b Christian Doppler Klinik   (Austria)

Author keywords

Cytochrome P450 enzymes; Drug interactions; Genetic polymorphism; Metabolism; Pharmacokinetics

Indexed keywords

CYTOCHROME P450; CYTOCHROME P450 2C9; CYTOCHROME P450 2D6; PSYCHOTROPIC AGENT;

BIOTRANSFORMATION; DRUG ABSORPTION; DRUG EFFICACY; DRUG ELIMINATION; DRUG INTERACTION; DRUG METABOLISM; DRUG PROTEIN BINDING; ENZYME ACTIVITY; ETHNIC DIFFERENCE; GENETIC POLYMORPHISM; HUMAN; REVIEW;

EID: 1542381013     PISSN: 09486259     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (20)

1. Aichhorn W., C. Stuppäck: Interaktionen und Pharmakokinetik von Psychopharmaka, Teil 2. Neuropsychiatrie 17 51-60 (2003).
2. Mutschler E.: Arzneimittelwirkungen. Lehrbuch der Pharmakologie und Toxikologie. Wissenschaftliche Verlagsgesellschaft mbH, Stuttgart 1997.
3. Forth W., D. Henschler, W. Rummel, K. Stark: Allgemeine und spezielle Pharmakologie und Toxikologie. Spektrum Akademischer Verlag, Heidelberg 1998.
4. Stryer L.: Biochemie. Spektrum Akademischer Verlag, Heidelberg 1999.
5. Nebert D.W., D.R. Nelson, R. Feyereisen: Evolution of the cytochrome P450 genes. Xenobiotica 19, 1149-1160 (1989).
6. Nebert D.W., M.Z. Dieter: The evolution of drug metabolism. Pharmacology 61, 124-135 (2000).
7. Hedlund E., J.A. Gustafsson, M. Warner: Cytochrome P450 in the brain; a review. Curr. Drug Metab. 2. 245-263 (2001).
8. Warner M., J.A. Gustafsson: Cytochrome P450 in the brain; neuroendocrine functions. Front. Neuroendocrinol. 16, 224-236 (1995).
9. Warner M., H. Hellmold, S. Yoshida, D. Liao, E. Hedlund, J.A. Gustafsson: Cytochrome P450 in the breast and brain; role in tissue-specific activation of xenobiotics. Mutat. Res. 376, 79-85 (1997).
10. Hedlund E., A. Wyss, T. Kainu, M. Backlund, C. Kohler, M. Pelto-Huikko, J.A. Gustafsson, M. Warner: Cytochrome P450 2D4 in the brain: specific neuronal regulation by clozapine and toluene. Mol. Pharmacol. 50, 342-350 (1996).
11. Nelson D.R., L. Koymans, T. Kamataki, J.J. Stegeman, R. Feyereisen, D.J. Waxman. M.R. Waterman, O. Gotoh, M.J. Coon, R.W. Estabrook, I.C. Gunsalus, D.W. Nebert: P450 superfamily: update on new sequences, gene mapping, accession numbers and nomenclature. Pharmacogenetics 6, 1-42 (1996).
12. Shimada T., H. Yamazaki, M. Mimura, Y. Inui, F.P. Guengerich: Interindividual variations in human liver cytochrome P450 enzymes involved in the oxidation of drugs, carcinogens and toxic chemicals, studies with liver microsomes of 30 Japanese and 30 Caucasians. J. Pharmacol. Exp. Ther. 270, 414-423 (1994).
13. Anzenbacher P., E. Anzenbacherova: Cytochromes P450 and metabolism of xenobiotics. Cell Mol. Life Sci. 58, 737-747 (2001).
14. Marez D., M. Legrand, N. Sabbagh, J.M. Guidice, C. Spire, J.J. Lafitte, U.A. Meyer, F. Broly: Polymorphism of the cytochrome P450 CYP2D6 gene in a European population: characterization of 48 mutations and 53 alleles, their frequencies and evolution. Pharmacogenetics 7, 193-202 (1997).
15. Coutts R.T., L.J. Urichuk: Polymorphic cytochromes P450 and drugs used in psychiatry. Cell Mol. Neurobiol. 19, 325-354 (1999).
16. Alvan G., P. Bechtel, L. Iselius, U. Gundert-Remy: Hydroxylation polymorphisms of debrisoquine and mephenytoin in European populations. Eur. J. Clin. Pharmacol. 39, 533-537 (1990).
17. Sheweita S.A.: Drug-metabolizing enzymes: mechanisms and functions. Curr. Drug Metab. 1, 107-132 (2000).
18. Sommers D.K., J. Moncrieff, J. Avenant: Polymorphism of the 4-hydroxylation of debrisoquine in the San Bushmen of Southern Africa. Hum. Toxicol. 7, 273-276 (1988).
19. von Moltke L.L., D.J. Greenblatt, J.M. Grasi, B.W. Granda, K. Venkatakrishnan, J. Schmider, J.S. Harmatz, R.I. Shader: Multiple human cytochromes contribute to biotransformation of dextromethorphan invitro, role of CYP2C9, CYP2C19, CYP2D6 and CYP3A. J. Pharm. Pharmacol. 50, 997-1004 (1998).
20. Streetman D.S., R.E. Ellis, A.N. Nafziger, J.S. Leeder, A. Gaedigk, R. Gotschall, G.L. Kearns, J.S. Bertino Jr.: Dose dependency of dextromethorphan for cytochrome P450 2D6 (CYP2D6) phenotyping. Clin. Pharmacol. Ther. 66, 535-541 (1999).